Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-20-072892
Filing Date
2020-06-12
Accepted
2020-06-12 16:01:40
Documents
1
Group Members
KOH, BONGSHAH, NIMISHVENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.VHCP CO-INVESTMENT HOLDINGS II, LLCVHCP CO-INVESTMENT HOLDINGS III, LLCVHCP MANAGEMENT II, LLCVHCP MANAGEMENT III, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tm2022295-1_sc13g.htm SC 13G 214749
  Complete submission text file 0001104659-20-072892.txt   216671
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Subject) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87188 | Film No.: 20960205
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 BRYANT PARK 23RD FLOOR NEW YORK NY 10018
Business Address 7 BRYANT PARK 23RD FLOOR NEW YORK NY 10018 650 475 3734
Venrock Healthcare Capital Partners II, L.P. (Filed by) CIK: 0001602264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G